| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United States | 10 | |
| #2 | EPO (European Patent Office) | 5 | |
| #3 | WIPO (World Intellectual Property Organization) | 5 | |
| #4 | Australia | 2 | |
| #5 | Brazil | 2 | |
| #6 | Canada | 2 | |
| #7 | China | 2 | |
| #8 | Israel | 2 | |
| #9 | Japan | 2 | |
| #10 | Republic of Korea | 2 | |
| #11 | Mexico | 2 | |
| #12 | Hungary | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Organic fine chemistry |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Therapeutic chemical compounds | |
| #3 | Peptides | |
| #4 | Acyclic or carbocyclic compounds | |
| #5 | Steroids | |
| #6 | Sugars | |
| #7 | Heterocyclic compounds |
| # | Name | Total Patents |
|---|---|---|
| #1 | Gillings Mireille | 22 |
| #2 | Rolland Alain | 18 |
| #3 | Bissonnette Reid P | 15 |
| #4 | Elliott Gary | 5 |
| #5 | Bissonnette Reid | 5 |
| #6 | Kyas Andreas | 4 |
| #7 | Goodenow Robert | 4 |
| #8 | Paterniti James R | 4 |
| #9 | Reid P Bissonnette | 4 |
| #10 | Mireille Gillings | 4 |
| Publication | Filing date | Title |
|---|---|---|
| US2020383961A1 | Triplet therapies of hdac inhibitors, pd-l1 and/or pd-1 inhibitors, and ctla-4 inhibitors | |
| US2020316024A1 | Sulcardine salts | |
| WO2020123824A1 | Sulcardine administration for treatment of acute atrial fibrillation | |
| US2019046513A1 | Combination therapies of hdac inhibitors and tubulin inhibitors | |
| KR20190022521A | HDAC Inhibitors and PD-L1 Inhibitors | |
| WO2017197140A1 | Combination therapies of hdac inhibitors and pd-l1 inhibitors | |
| AU2011349207A1 | Purified cardiogenin isomer and related methods | |
| EP3311810A1 | Use of sulcardine for the treatment of atrial fibrillation |